{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:12:41Z","timestamp":1793725961921,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:00:00Z","timestamp":1775088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-026-01398-8","type":"journal-article","created":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:59:31Z","timestamp":1775102371000},"page":"534-545","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Persistent IFN-I signaling inhibits mitochondrial oxidative metabolism in CD8+ T cells during HIV-1 infection under cART"],"prefix":"10.1038","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0669-5037","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8245-5583","authenticated-orcid":false,"given":"Fei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengmeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6342-844X","authenticated-orcid":false,"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuchen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4646-6928","authenticated-orcid":false,"given":"Runpeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1757-1411","authenticated-orcid":false,"given":"Haisheng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-455X","authenticated-orcid":false,"given":"Wei","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilu","family":"Goonetilleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Brad","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0350-5560","authenticated-orcid":false,"given":"Lishan","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,2]]},"reference":[{"key":"1398_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/imr.12823","volume":"292","author":"C Fenwick","year":"2019","unstructured":"Fenwick C, Joo V, Jacquier P, Noto A, Banga R, Perreau M, et al. T-cell exhaustion in HIV infection. Immunol Rev. 2019;292:149\u201363.","journal-title":"Immunol Rev"},{"key":"1398_CR2","doi-asserted-by":"publisher","first-page":"e1005661","DOI":"10.1371\/journal.ppat.1005661","volume":"12","author":"M Hoffmann","year":"2016","unstructured":"Hoffmann M, Pantazis N, Martin GE, Hickling S, Hurst J, Meyerowitz J, et al. Exhaustion of activated CD8 T cells predicts disease progression in primary HIV-1 infection. PLoS Pathog. 2016;12:e1005661.","journal-title":"PLoS Pathog"},{"key":"1398_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-med-042909-093756","volume":"62","author":"SG Deeks","year":"2011","unstructured":"Deeks SG. HIV infection, inflammation, immunosenescence, and aging. Annu Rev Med. 2011;62:141\u201355.","journal-title":"Annu Rev Med"},{"key":"1398_CR4","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature09907","volume":"472","author":"JW Schoggins","year":"2011","unstructured":"Schoggins JW, Wilson SJ, Panis M, Murphy MY, Jones CT, Bieniasz P, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481\u20135.","journal-title":"Nature"},{"key":"1398_CR5","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1126\/science.1235214","volume":"340","author":"JR Teijaro","year":"2013","unstructured":"Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, et al. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science. 2013;340:207\u201311.","journal-title":"Science"},{"key":"1398_CR6","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1126\/science.1235208","volume":"340","author":"EB Wilson","year":"2013","unstructured":"Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, et al. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science. 2013;340:202\u20137.","journal-title":"Science"},{"key":"1398_CR7","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1128\/JVI.02228-07","volume":"82","author":"AR Sedaghat","year":"2008","unstructured":"Sedaghat AR, German J, Teslovich TM, Cofrancesco J Jr, Jie CC, Talbot CC Jr, et al. Chronic CD4+ T-cell activation and depletion in human immunodeficiency virus type 1 infection: type I interferon-mediated disruption of T-cell dynamics. J Virol. 2008;82:1870\u201383.","journal-title":"J Virol"},{"key":"1398_CR8","doi-asserted-by":"publisher","first-page":"3477","DOI":"10.1128\/JVI.01552-06","volume":"81","author":"MD Hyrcza","year":"2007","unstructured":"Hyrcza MD, Kovacs C, Loutfy M, Halpenny R, Heisler L, Yang S, et al. Distinct transcriptional profiles in ex vivo CD4+ and CD8+ T cells are established early in human immunodeficiency virus type 1 infection and are characterized by a chronic interferon response as well as extensive transcriptional changes in CD8+ T cells. J Virol. 2007;81:3477\u201386.","journal-title":"J Virol"},{"key":"1398_CR9","doi-asserted-by":"publisher","first-page":"e1000781","DOI":"10.1371\/journal.ppat.1000781","volume":"6","author":"M Rotger","year":"2010","unstructured":"Rotger M, Dang KK, Fellay J, Heinzen EL, Feng S, Descombes P, et al. Genome-wide mRNA expression correlates of viral control in CD4+ T cells from HIV-1-infected individuals. PLoS Pathog. 2010;6:e1000781.","journal-title":"PLoS Pathog"},{"key":"1398_CR10","doi-asserted-by":"publisher","first-page":"7886","DOI":"10.1128\/JVI.02612-09","volume":"84","author":"LD Harris","year":"2010","unstructured":"Harris LD, Tabb B, Sodora DL, Paiardini M, Klatt NR, Douek DC, et al. Downregulation of robust acute type I interferon responses distinguishes nonpathogenic simian immunodeficiency virus (SIV) infection of natural hosts from pathogenic SIV infection of rhesus macaques. J Virol. 2010;84:7886\u201391.","journal-title":"J Virol"},{"key":"1398_CR11","first-page":"3556","volume":"119","author":"SE Bosinger","year":"2009","unstructured":"Bosinger SE, Li Q, Gordon SN, Klatt NR, Duan L, Xu L, et al. Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys. J Clin Invest. 2009;119:3556\u201372.","journal-title":"J Clin Invest"},{"key":"1398_CR12","first-page":"3544","volume":"119","author":"B Jacquelin","year":"2009","unstructured":"Jacquelin B, Mayau V, Targat B, Liovat AS, Kunkel D, Petitjean G, et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J Clin Invest. 2009;119:3544\u201355.","journal-title":"J Clin Invest"},{"key":"1398_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1172\/JCI90745","volume":"127","author":"L Cheng","year":"2017","unstructured":"Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T-cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269\u201379.","journal-title":"J Clin Invest"},{"key":"1398_CR14","doi-asserted-by":"crossref","unstructured":"Cheng L, Yu H, Li G, Li F, Ma J, Li J, et al. Type I interferons suppress viral replication but contribute to T-cell depletion and dysfunction during chronic HIV-1 infection. JCI Insight. 2017;2:e94366.","DOI":"10.1172\/jci.insight.94366"},{"key":"1398_CR15","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1172\/JCI89488","volume":"127","author":"A Zhen","year":"2017","unstructured":"Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260\u20138.","journal-title":"J Clin Invest"},{"key":"1398_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/imr.12858","volume":"295","author":"L Makowski","year":"2020","unstructured":"Makowski L, Chaib M, Rathmell JC. Immunometabolism: from basic mechanisms to translation. Immunol Rev. 2020;295:5\u201314.","journal-title":"Immunol Rev"},{"key":"1398_CR17","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cell.2017.04.004","volume":"169","author":"MD Buck","year":"2017","unstructured":"Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic Instruction of Immunity. Cell. 2017;169:570\u201386.","journal-title":"Cell"},{"key":"1398_CR18","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20151159","volume":"212","author":"MD Buck","year":"2015","unstructured":"Buck MD, O\u2019Sullivan D, Pearce EL. T-cell metabolism drives immunity. J Exp Med. 2015;212:1345\u201360.","journal-title":"J Exp Med"},{"key":"1398_CR19","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, Ha SJ, Kaech SM, Haining WN, Sarkar S, Kalia V, et al. Molecular signature of CD8+ T-cell exhaustion during chronic viral infection. Immunity. 2007;27:670\u201384.","journal-title":"Immunity"},{"key":"1398_CR20","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.celrep.2016.06.078","volume":"16","author":"A Schurich","year":"2016","unstructured":"Schurich A, Pallett LJ, Jajbhay D, Wijngaarden J, Otano I, Gill US, et al. Distinct metabolic requirements of exhausted and functional virus-specific CD8 T cells in the same host. Cell Rep. 2016;16:1243\u201352.","journal-title":"Cell Rep"},{"key":"1398_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","volume":"37","author":"LM McLane","year":"2019","unstructured":"McLane LM, Abdel-Hakeem MS, Wherry EJ. CD8 T-cell exhaustion during chronic viral infection and cancer. Annu Rev Immunol. 2019;37:457\u201395.","journal-title":"Annu Rev Immunol"},{"key":"1398_CR22","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/s42255-019-0081-4","volume":"1","author":"M Angin","year":"2019","unstructured":"Angin M, Volant S, Passaes C, Lecuroux C, Monceaux V, Dillies MA, et al. Metabolic plasticity of HIV-specific CD8(+) T cells is associated with enhanced antiviral potential and natural control of HIV-1 infection. Nat Metab. 2019;1:704\u201316.","journal-title":"Nat Metab"},{"key":"1398_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ebiom.2019.03.004","volume":"42","author":"L Tarancon-Diez","year":"2019","unstructured":"Tarancon-Diez L, Rodriguez-Gallego E, Rull A, Peraire J, Vilades C, Portilla I, et al. Immunometabolism is a key factor for the persistent spontaneous elite control of HIV-1 infection. EBioMedicine. 2019;42:86\u201396.","journal-title":"EBioMedicine"},{"key":"1398_CR24","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-020-0793-3","volume":"21","author":"YR Yu","year":"2020","unstructured":"Yu YR, Imrichova H, Wang H, Chao T, Xiao Z, Gao M, et al. Disturbed mitochondrial dynamics in CD8(+) TILs reinforce T-cell exhaustion. Nat Immunol. 2020;21:1540\u201351.","journal-title":"Nat Immunol"},{"key":"1398_CR25","doi-asserted-by":"publisher","first-page":"473","DOI":"10.3389\/fimmu.2017.00473","volume":"8","author":"T Chao","year":"2017","unstructured":"Chao T, Wang H, Ho PC. Mitochondrial control and guidance of cellular activities of T cells. Front Immunol. 2017;8:473.","journal-title":"Front Immunol"},{"key":"1398_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41421-021-00367-x","volume":"8","author":"XM Wang","year":"2022","unstructured":"Wang XM, Zhang JY, Xing X, Huang HH, Xia P, Dai XP, et al. Global transcriptomic characterization of T cells in individuals with chronic HIV-1 infection. Cell Discov 2022;8:29.","journal-title":"Cell Discov"},{"key":"1398_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/s42255-020-0256-z","volume":"2","author":"RI Klein Geltink","year":"2020","unstructured":"Klein Geltink RI, Edwards-Hicks J, Apostolova P, O\u2019Sullivan D, Sanin DE, Patterson AE, et al. Metabolic conditioning of CD8(+) effector T cells for adoptive cell therapy. Nat Metab. 2020;2:703\u201316.","journal-title":"Nat Metab"},{"key":"1398_CR28","doi-asserted-by":"publisher","first-page":"e101920","DOI":"10.1371\/journal.pone.0101920","volume":"9","author":"S Hua","year":"2014","unstructured":"Hua S, Lecuroux C, Saez-Cirion A, Pancino G, Girault I, Versmisse P, et al. Potential role for HIV-specific CD38-\/HLA-DR+ CD8+ T cells in viral suppression and cytotoxicity in HIV controllers. PLoS ONE. 2014;9:e101920.","journal-title":"PLoS ONE"},{"key":"1398_CR29","doi-asserted-by":"publisher","first-page":"e3738","DOI":"10.1097\/MD.0000000000003738","volume":"95","author":"S Amu","year":"2016","unstructured":"Amu S, Lantto Graham R, Bekele Y, Nasi A, Bengtsson C, Rethi B, et al. Dysfunctional phenotypes of CD4+ and CD8+ T cells are comparable in patients initiating ART during early or chronic HIV-1 infection. Medicine. 2016;95:e3738.","journal-title":"Medicine"},{"key":"1398_CR30","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1097\/00002030-200309050-00006","volume":"17","author":"MD Hazenberg","year":"2003","unstructured":"Hazenberg MD, Otto SA, van Benthem BH, Roos MT, Coutinho RA, Lange JM, et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS. 2003;17:1881\u20138.","journal-title":"AIDS"},{"key":"1398_CR31","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.4049\/jimmunol.1200646","volume":"191","author":"G Breton","year":"2013","unstructured":"Breton G, Chomont N, Takata H, Fromentin R, Ahlers J, Filali-Mouhim A, et al. Programmed death-1 is a marker for abnormal distribution of na\u00efve\/memory T-cell subsets in HIV-1 infection. J Immunol. 2013;191:2194\u2013204.","journal-title":"J Immunol"},{"key":"1398_CR32","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1172\/JCI99005","volume":"128","author":"L Cheng","year":"2018","unstructured":"Cheng L, Wang Q, Li G, Banga R, Ma J, Yu H, et al. TLR3 agonist and CD40-targeting vaccination induces immune responses and reduces HIV-1 reservoirs. J Clin Invest. 2018;128:4387\u201396.","journal-title":"J Clin Invest"},{"key":"1398_CR33","doi-asserted-by":"crossref","unstructured":"Morrish F, Hockenbery D. MYC and mitochondrial biogenesis. Cold Spring Harb Perspect Med. 2014;4:a014225.","DOI":"10.1101\/cshperspect.a014225"},{"key":"1398_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.3389\/fimmu.2016.00630","volume":"7","author":"SD Fritsch","year":"2016","unstructured":"Fritsch SD, Weichhart T. Effects of interferons and viruses on metabolism. Front Immunol. 2016;7:630.","journal-title":"Front Immunol"},{"key":"1398_CR35","doi-asserted-by":"publisher","first-page":"13184","DOI":"10.1074\/jbc.271.22.13184","volume":"271","author":"JA Lewis","year":"1996","unstructured":"Lewis JA, Huq A, Najarro P. Inhibition of mitochondrial function by interferon. J Biol Chem. 1996;271:13184\u201390.","journal-title":"J Biol Chem"},{"key":"1398_CR36","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.canlet.2016.02.047","volume":"375","author":"YA Hsu","year":"2016","unstructured":"Hsu YA, Huang CC, Kung YJ, Lin HJ, Chang CY, Lee KR, et al. The anti-proliferative effects of type I IFN involve STAT6-mediated regulation of SP1 and BCL6. Cancer Lett. 2016;375:303\u201312.","journal-title":"Cancer Lett"},{"key":"1398_CR37","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.immuni.2016.06.006","volume":"44","author":"D Wu","year":"2016","unstructured":"Wu D, Sanin DE, Everts B, Chen Q, Qiu J, Buck MD, et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity. 2016;44:1325\u201336.","journal-title":"Immunity"},{"key":"1398_CR38","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-021-00898-1","volume":"22","author":"H Guo","year":"2021","unstructured":"Guo H, Wang Q, Ghneim K, Wang L, Rampanelli E, Holley-Guthrie E, et al. Multiomics analyses reveal that HIV-1 alters CD4(+) T-cell immunometabolism to fuel virus replication. Nat Immunol. 2021;22:423\u201333.","journal-title":"Nat Immunol"},{"key":"1398_CR39","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1097\/QAD.0000000000000128","volume":"28","author":"CS Palmer","year":"2014","unstructured":"Palmer CS, Ostrowski M, Gouillou M, Tsai L, Yu D, Zhou J, et al. Increased glucose metabolic activity is associated with CD4+ T-cell activation and depletion during chronic HIV infection. AIDS. 2014;28:297\u2013309.","journal-title":"AIDS"},{"key":"1398_CR40","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.cmet.2018.11.015","volume":"29","author":"JC Valle-Casuso","year":"2019","unstructured":"Valle-Casuso JC, Angin M, Volant S, Passaes C, Monceaux V, Mikhailova A, et al. Cellular metabolism is a major determinant of HIV-1 reservoir seeding in CD4(+) T cells and offers an opportunity to tackle infection. Cell Metab. 2019;29:611\u201326 e5.","journal-title":"Cell Metab"},{"key":"1398_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.cmet.2018.08.012","volume":"28","author":"F Wang","year":"2018","unstructured":"Wang F, Zhang S, Vuckovic I, Jeon R, Lerman A, Folmes CD, et al. Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab. 2018;28:463\u201375 e4.","journal-title":"Cell Metab"},{"key":"1398_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10168-1","volume":"12","author":"I Aiestaran-Zelaia","year":"2022","unstructured":"Aiestaran-Zelaia I, Sanchez-Guisado MJ, Villar-Fernandez M, Azkargorta M, Fadon-Padilla L, Fernandez-Pelayo U, et al. 2 deoxy-D-glucose augments the mitochondrial respiratory chain in heart. Sci Rep. 2022;12:6890.","journal-title":"Sci Rep"},{"key":"1398_CR43","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/JLB.4MR1019-189R","volume":"107","author":"X Yang","year":"2020","unstructured":"Yang X, Su B, Zhang X, Liu Y, Wu H, Zhang T. Incomplete immune reconstitution in HIV\/AIDS patients on antiretroviral therapy: Challenges of immunological nonresponders. J Leukoc Biol. 2020;107:597\u2013612.","journal-title":"J Leukoc Biol"},{"key":"1398_CR44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/nm.3781","volume":"21","author":"Y Fukazawa","year":"2015","unstructured":"Fukazawa Y, Lum R, Okoye AA, Park H, Matsuda K, Bae JY, et al. B-cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers. Nat Med. 2015;21:132\u20139.","journal-title":"Nat Med"},{"key":"1398_CR45","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1084\/jem.20121932","volume":"210","author":"M Perreau","year":"2013","unstructured":"Perreau M, Savoye AL, De Crignis E, Corpataux JM, Cubas R, Haddad EK, et al. Follicular helper T cells serve as the major CD4 T-cell compartment for HIV-1 infection, replication, and production. J Exp Med. 2013;210:143\u201356.","journal-title":"J Exp Med"},{"key":"1398_CR46","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/pros.21172","volume":"70","author":"M Stein","year":"2010","unstructured":"Stein M, Lin H, Jeyamohan C, Dvorzhinski D, Gounder M, Bray K, et al. Targeting tumor metabolism with 2-deoxyglucose in patients with castrate-resistant prostate cancer and advanced malignancies. Prostate. 2010;70:1388\u201394.","journal-title":"Prostate"},{"key":"1398_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.899633","volume":"13","author":"Z Huang","year":"2022","unstructured":"Huang Z, Chavda VP, Vora LK, Gajjar N, Apostolopoulos V, Shah N, et al. 2-Deoxy-D-glucose and its derivatives for the COVID-19 treatment: an update. Front Pharmacol. 2022;13:899633.","journal-title":"Front Pharmacol"},{"key":"1398_CR48","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.1","volume":"4","author":"C Soneson","year":"2015","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.","journal-title":"F1000Res"}],"container-title":["Cellular &amp; Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01398-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01398-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01398-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:01:54Z","timestamp":1777500114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-026-01398-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,2]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["1398"],"URL":"https:\/\/doi.org\/10.1038\/s41423-026-01398-8","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,2]]},"assertion":[{"value":"24 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests. LS is an editorial board member of\n                      Cellular & Molecular Immunology\n                      , but he has not been involved in peer review or decision-making related to the article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}